A family walks across a green summer meadow, seen from behind.

Taking part and travel

Treatment abroad and clinical studies: what to know

Some families think about treatment in another country, or about a clinical study. Here are your rights and the rules for travel to the EU.

  • 3 min read
  • Updated 19 November 2026

Most important in brief

  • Taking part in a study is voluntary. You can stop at any time.
  • With a biometric passport, people from all six countries can usually travel visa-free, for up to 90 days in 180.
  • The European Health Insurance Card does not cover people insured in these countries. Agree costs in writing beforehand.

At a glance

TopicWhat appliesGood to know
Visa-free to the Schengen area
Yes, with a biometric passport from Serbia, Albania, Bosnia and Herzegovina, North Macedonia and Montenegro. Kosovo: since 1 January 2024.
Up to 90 days in 180. Short stays only.
EES (Entry/Exit System)
In operation since 10 April 2026.
Your details are recorded electronically at the border.
ETIAS (travel authorisation)
Not yet in operation (as of 12 November 2026).
The start will be announced several months ahead.
European Health Insurance Card
Does not cover people insured in the six countries.
Agree costs for treatment, travel and accommodation in writing beforehand.
Taking part in a study
Always voluntary.
You can stop at any time.

Your rights in a study

Taking part in a clinical study is voluntary. You can say no, or withdraw your consent later. The information must be understandable to you. This is set out in Regulation (EU) No 536/2014.

Each country decides in which languages a study’s documents must be available (Article 26). In another country they are therefore often only in that country’s language. Ask early whether there is a version in your language, or whether an interpreter can be present.

If someone is harmed by a study, Article 76 of this regulation requires arrangements for compensation.

It applies to studies that take place in an EU country and is tied to where the study takes place, not to where you live. Still ask to see which insurance applies and whom to contact if harm occurs.

Details and legal basis: visas, border and insurance

Travelling to the EU: visas

With a biometric passport from Serbia, Albania, Bosnia and Herzegovina, North Macedonia or Montenegro, you can usually travel to the Schengen area without a visa, for up to 90 days in any 180-day period (Regulation (EU) 2018/1806).

The same has applied to biometric passports from Kosovo since 1 January 2024 (Regulation (EU) 2023/850). Passports issued by the Serbian Coordination Directorate are excluded.

This applies to short stays. A longer treatment may need a different permit. Ask the embassy of the country you plan to visit.

At the border: EES and ETIAS

Since 10 April 2026, the EU Entry/Exit System (EES) has been fully in operation. Your details are recorded electronically at the border.

ETIAS, a travel authorisation you apply for online in advance, is not yet in operation. The Commission says it will announce the start several months ahead (European Commission; travel-europe.europa.eu, as of 12 November 2026).

Insurance and costs abroad

The European Health Insurance Card (EHIC) only covers people insured in an EU country (Your Europe). None of the six countries is an EU member. So before you travel, get it in writing who pays for treatment, travel and accommodation.

Before you travel

Studies in the region

This site does not arrange participation. Studies taking on participants in the region are named, factually, under Updates. Vela Clinical will offer an overview of ongoing studies:

Current clinical studies – Vela Clinical An overview from Vela Clinical, the organisation behind this site. Not a recommendation of any particular study. Link coming soon.

Sources

  1. EUR-Lex: Regulation (EU) No 536/2014
  2. EUR-Lex: Regulation (EU) 2018/1806
  3. EUR-Lex: Regulation (EU) 2023/850
  4. European Commission: Smart Borders
  5. travel-europe.europa.eu: ETIAS FAQ
  6. Your Europe: EHIC (page last modified 16 September 2026)

All sources last checked on 12 November 2026, unless another date is given.